Wilmot Cancer Institute, University of Rochester
Upstate New York's Wilmot Cancer Institute, NCI-designated in 2024 and a national leader in geriatric oncology and cancer-control research.
Wilmot Cancer Institute at the University of Rochester Medical Center received NCI designation in 2024 and serves a largely rural 27-county region of upstate New York. It hosts one of the NCI Community Oncology Research Program's national research bases, historically led by Gary Morrow, whose trials on nausea, fatigue and exercise defined cancer-control research; Karen Mustian's exercise oncology and Supriya Mohile's geriatric assessment trials (GAP70+) showed that assessing older patients reduces chemotherapy toxicity. Jonathan Friedberg, editor-in-chief of the Journal of Clinical Oncology, leads its lymphoma programme. Director Jonathan Friedberg and cancer biologist Hartmut Land have built basic programmes in tumour evolution and haematologic malignancy.
- Geriatric oncology
- Cancer control and survivorship (NCORP Research Base)
- Lymphoma
Pages like this
not linked directly; found by shared links- InstitutionEuropean Society for Clinical Nutrition and Metabolism
Shares Geriatric assessment, Exercise & lifestyle oncology, Older and multimorbid patients are excluded and undertreated.
- IdeaCatch wasting early with a smart scale and a step counter
Shares Geriatric assessment, Exercise & lifestyle oncology, Toxicity and quality of life are undervalued.
- IdeaGeriatrician co-management for older patients having cancer surgery
Shares Geriatric assessment, Older and multimorbid patients are excluded and undertreated.
- IdeaParallel real-world cohorts for sicker patients alongside every pivotal trial
Shares Geriatric assessment, Older and multimorbid patients are excluded and undertreated.
- IdeaStop screening by life expectancy, not birthday, with a tool in the record
Shares Geriatric assessment, Older and multimorbid patients are excluded and undertreated.
- IdeaGeriatric assessment by default for every patient over 70 starting cancer treatment
Shares Geriatric assessment, Older and multimorbid patients are excluded and undertreated, Toxicity and quality of life are undervalued.
- IdeaPragmatic trials in patients over 75 with function, not just survival, as the primary endpoint
Shares Geriatric assessment, Older and multimorbid patients are excluded and undertreated.
- IdeaA standard handoff with medication reconciliation at every cancer care transition
Shares Older and multimorbid patients are excluded and undertreated, Toxicity and quality of life are undervalued.